Virbac Stock Value
Virbac Company Info
EPS Growth 5Y
19,35%
Market Cap
€2,94 B
Long-Term Debt
€0,15 B
Annual earnings
N/A
Dividend
€1,42
Dividend Yield
0,41%
Founded
1968
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
€415,00
19.42%
Last Update: 04/07/2026
Analysts: 9
Highest Price Target €440,00
Average Price Target €415,00
Lowest Price Target €368,00
In the last five quarters, Virbac’s Price Target has risen from €386,09 to €391,61 - a 1,43% increase. Seven analysts predict that Virbac’s share price will increase in the coming year, reaching €415,00. This would represent an increase of 19,42%.
Top growth stocks in the health care sector (5Y.)
What does Virbac do?
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals.
Business Segments
The company is structured into geographical segments, which include France, Europe (excluding France), Latin America, North America, Asia Pacific, and Africa & the Middle East. The segments are defined by geography and by the nature of the markets served, which include companion animals and farm animals.
Business Strategy
The company’s business strategy focuses on enhan...
Virbac Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Industry Sales:**
- Animal Health: 100% (Virbac SA specializes in animal health products)
**TOP 3 Markets:**
- USA: approx. 35%
- Europe (excluding France): approx. 25%
- France: approx. 15%
Virbac SA generates its sales entirely from the animal health industry, with a focus on products for live...
At which locations are the company’s products manufactured?
**Production sites of Virbac SA:**
Virbac SA is a globally operating company in the animal health industry and operates production facilities in several countries worldwide. The key production sites include:
- **France:** Headquarters and significant production capacities.
- **USA:** Production fa...
What strategy does Virbac pursue for future growth?
**Revenue Growth:** 8.2% (2024)
**Research & Development Investments:** 12% of revenue (2024)
Virbac SA pursues a growth strategy that heavily focuses on innovation and expansion into emerging markets. The company invests significantly in research and development to develop new products and enh...
Which raw materials are imported and from which countries?
**Main raw materials:** Pharmaceutical active ingredients, excipients, packaging materials
**Countries of origin:** China, India, USA, Germany
Virbac SA, as a leading company in the animal health industry, imports a variety of raw materials needed for the production of their products. The most imp...
How strong is the company’s competitive advantage?
**Market share in the animal health industry:** 5% (estimated for 2025)
**R&D expenses:** 8% of revenue (2024)
**Geographical presence:** Over 100 countries (2024)
Virbac SA is a significant player in the animal health industry and has gained a solid competitive advantage through its wide r...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** approximately 45% (estimated for 2025)
**Insider Buys/Sells:** No significant transactions in the last year (estimated for 2025)
The institutional investor share in Virbac SA is estimated to be around 45%. This demonstrates the confidence of institutional investor...
What percentage market share does Virbac have?
**Market share of Virbac SA:** 5% (estimated, 2025)
**Top competitors and their market shares:**
1. **Zoetis Inc.:** 25%
2. **Elanco Animal Health:** 15%
3. **Boehringer Ingelheim Animal Health:** 12%
4. **Merck Animal Health:** 10%
5. **Bayer Animal Health:** 8%
6. **Virbac SA:** 5%
7. **Ceva Sant...
Is Virbac stock currently a good investment?
**Revenue Growth:** 8.5% (2024)
**Profit Growth:** 10.2% (2024)
**Research & Development (R&D) Expenses:** 7.5% of revenue (2024)
Virbac SA achieved solid revenue growth of 8.5% in 2024, driven by strong demand for their animal health products. Profit growth was at 10.2%, indicating efficie...
Does Virbac pay a dividend – and how reliable is the payout?
**Dividend yield:** 1.2% (2024)
**Payout ratio:** 30% (2024)
Virbac SA has regularly paid dividends in recent years. The dividend yield in 2024 was approximately 1.2%, which is considered moderate compared to other companies in the industry. The 30% payout ratio indicates that the company follo...
